IONIQ Sciences Featured as Innovator at the Forefront by Healthcare Sales & Marketing
IONIQ Sciences is featured in Healthcare Sales & Marketing’s (HS&M) recent issue as an “innovator at the forefront.” HS&M is dedicated to sales and marketing healthcare professionals across all sectors and they highlight major movers in the industry, spotlight cutting-edge companies, and feature visionary thinking and acting. We appear in an article stressing the importance of continued research and innovation focused on fundamental health issues in parallel with the focused efforts on Covid-19. Cancer isn’t just a fundamental health issue – it’s a scourge to humanity. One in two people will get cancer during their lifetime and one in five will die. Clinical evidence demonstrates the five-year survival rates approach 90% when cancer is diagnosed in its earliest stages, versus less than 10% in later stages. By detecting the body’s earliest response to cancer, we aim to expand the therapeutic window, dramatically improve survivability, and reduce the cost of healthcare. We’re thrilled that external recognition continues to affirm our mission to lessen the deadly scourge of cancer.